Rekasi, Z <br/><br/>
Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.  [electronic resource] 

 -  The Prostate  Aug 2001 
 - 188-99 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0270-4137 
<br/><br/><label>Standard No.: </label>10.1002/pros.1097  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgens--pharmacology<br/>Animals<br/>Cyclic AMP--biosynthesis<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Gene Expression Regulation, Neoplastic<br/>Growth Hormone-Releasing Hormone--antagonists & inhibitors<br/>Male<br/>Mice<br/>Prostate-Specific Antigen--biosynthesis<br/>Prostatic Neoplasms--genetics<br/>Tumor Cells, Cultured<br/>Vasoactive Intestinal Peptide--pharmacology